Natera, Inc. (NTRA) Announces Results From the SINERGY Trial

Natera, Inc. (NASDAQ:NTRA) is one of the best strong buy healthcare stocks to invest in. On February 24, Natera, Inc. (NASDAQ:NTRA) announced results from the SINERGY trial, a Phase 2 study in recurrent or metastatic head and neck squamous cell carcinoma, with the data recently presented in an oral plenary at the 2026 MHNCS. Management reported that 27 patients received initial treatment of either immunotherapy alone or in combination with chemotherapy in the trial, and based on Signatera ctDNA dynamics du ...